The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial

Sledge, George W.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Inoue, Kenichi; Pivot, Xavier; Burdaeva, Olga; Okera, Meena; Masuda, Norikazu; Kaufman, Peter A.; Koh, Han; Grischke, Eva-Maria; Conte, PierFranco; Lu, Yi; Barriga, Susana; Hurt, Karla; Frenzel, Martin; Johnston, Stephen; Llombart-Cussac, Antonio

dc.contributor.author	Grischke, Eva-Maria
dc.date.accessioned	2020-11-03T07:43:12Z
dc.date.available	2020-11-03T07:43:12Z
dc.date.issued	2020
dc.identifier.issn	2374-2445
dc.identifier.uri	http://hdl.handle.net/10900/109078
dc.language.iso	en	de_DE
dc.publisher	Amer Medical Assoc	de_DE
dc.relation.uri	http://dx.doi.org/10.1001/jamaoncol.2019.4782	de_DE
dc.subject.ddc	610	de_DE
dc.title	The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2 A Randomized Clinical Trial	de_DE
dc.type	Article	de_DE
dc.type	ConferenceObject	de_DE
utue.quellen.id	20200715072417_02265
utue.publikation.seiten	116-124	de_DE
utue.personen.roh	Sledge, George W.
utue.personen.roh	Toi, Masakazu
utue.personen.roh	Neven, Patrick
utue.personen.roh	Sohn, Joohyuk
utue.personen.roh	Inoue, Kenichi
utue.personen.roh	Pivot, Xavier
utue.personen.roh	Burdaeva, Olga
utue.personen.roh	Okera, Meena
utue.personen.roh	Masuda, Norikazu
utue.personen.roh	Kaufman, Peter A.
utue.personen.roh	Koh, Han
utue.personen.roh	Grischke, Eva-Maria
utue.personen.roh	Conte, PierFranco
utue.personen.roh	Lu, Yi
utue.personen.roh	Barriga, Susana
utue.personen.roh	Hurt, Karla
utue.personen.roh	Frenzel, Martin
utue.personen.roh	Johnston, Stephen
utue.personen.roh	Llombart-Cussac, Antonio
dcterms.isPartOf.ZSTitelID	Jama Oncology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	6	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE